Next Article in Journal
Cytotoxic Polyketides Isolated from the Deep-Sea-Derived Fungus Penicillium chrysogenum MCCC 3A00292
Previous Article in Journal
In Vitro Antiproliferative Evaluation of Synthetic Meroterpenes Inspired by Marine Natural Products
Open AccessArticle

Combination Formulation of Tetrodotoxin and Lidocaine as a Potential Therapy for Severe Arrhythmias

by 1,2,*,†, 1,2,†, 1,2, 1,2, 1,3 and 1,2
1
Third Institute of Oceanography, Ministry of Natural Resources, Xiamen 361005, China
2
Technical Innovation Center for Utilization of Marine Biological Resources, Ministry of Natural Resources, Xiamen 361005, China
3
College of Food and Biological Engineering, Jimei University, Xiamen 361021, China
*
Author to whom correspondence should be addressed.
They contributed equally to this work.
Mar. Drugs 2019, 17(12), 685; https://doi.org/10.3390/md17120685
Received: 14 November 2019 / Revised: 30 November 2019 / Accepted: 3 December 2019 / Published: 5 December 2019
Severe arrhythmias—such as ventricular arrhythmias—can be fatal, but treatment options are limited. The effects of a combined formulation of tetrodotoxin (TTX) and lidocaine (LID) on severe arrhythmias were studied. Patch clamp recording data showed that the combination of LID and TTX had a stronger inhibitory effect on voltage-gated sodium channel 1.5 (Nav1.5) than that of either TTX or LID alone. LID + TTX formulations were prepared with optimal stability containing 1 μg of TTX, 5 mg of LID, 6 mg of mannitol, and 4 mg of dextran-40 and then freeze dried. This formulation significantly delayed the onset and shortened the duration of arrhythmia induced by aconitine in rats. Arrhythmia-originated death was avoided by the combined formulation, with a decrease in the mortality rate from 64% to 0%. The data also suggests that the anti-arrhythmic effect of the combination was greater than that of either TTX or LID alone. This paper offers new approaches to develop effective medications against arrhythmias. View Full-Text
Keywords: Tetrodotoxin; lidocaine; combination preparation; arrhythmia; freeze dried powder Tetrodotoxin; lidocaine; combination preparation; arrhythmia; freeze dried powder
Show Figures

Figure 1

MDPI and ACS Style

Hong, B.; He, J.; Le, Q.; Bai, K.; Chen, Y.; Huang, W. Combination Formulation of Tetrodotoxin and Lidocaine as a Potential Therapy for Severe Arrhythmias. Mar. Drugs 2019, 17, 685. https://doi.org/10.3390/md17120685

AMA Style

Hong B, He J, Le Q, Bai K, Chen Y, Huang W. Combination Formulation of Tetrodotoxin and Lidocaine as a Potential Therapy for Severe Arrhythmias. Marine Drugs. 2019; 17(12):685. https://doi.org/10.3390/md17120685

Chicago/Turabian Style

Hong, Bihong; He, Jianlin; Le, Qingqing; Bai, Kaikai; Chen, Yongqiang; Huang, Wenwen. 2019. "Combination Formulation of Tetrodotoxin and Lidocaine as a Potential Therapy for Severe Arrhythmias" Mar. Drugs 17, no. 12: 685. https://doi.org/10.3390/md17120685

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop